51 research outputs found
Towards a standardised informed consent procedure for live donor nephrectomy:the PRINCE (Process of Informed Consent Evaluation) project-study protocol for a nationwide prospective cohort study
Introduction: Informed consent is mandatory for all (surgical) procedures, but it is even more important when it comes to living kidney donors undergoing surgery for the benefit of others. Donor education, leading to informed consent, needs to be carried out according to certain standards. Informed consent procedures for live donor nephrectomy vary per centre, and even per individual healthcare professional. The basis for a standardised, uniform surgical informed consent procedure for live donor nephrectomy can be created by assessing what information donors need to hear to prepare them for the operation and convalescence. Methods and analysis: The PRINCE (Process of Informed Consent Evaluation) project is a prospective, multicentre cohort study, to be carried out in all eight Dutch kidney transplant centres. Donor knowledge of the procedure and postoperative course will be evaluated by means of pop quizzes. A baseline cohort (prior to receiving any information from a member of the transplant team in one of the transplant centres) will be compared with a control group, the members of which receive the pop quiz on the day of admission for donor nephrectomy. Donor satisfaction will be evaluated for all donors who completed the admission pop-quiz. The primary end point is donor knowledge. In addition, those elements that have to be included in the standardised format informed consent procedure will be identified. Secondary end points are donor satisfaction, current informed consent practices in the different centres (eg, how many visits, which personnel, what kind of information is disclosed, in which format, etc) and correlation of donor knowledge with surgeons' estimation thereof. Ethics and dissemination: Approval for this study was obtained from the medical ethical committee of the Erasmus MC, University Medical Center, Rotterdam, on 18 February 2015. Secondary approval has been obtained from the local ethics committees in six participating centres. Approval in the last centre has been sought. Results: Outcome will be published in a scientific journal
Breaking and Fixing Anonymous Credentials for the Cloud
In an attribute-based credential (ABC) system, users obtain a digital certificate on their personal attributes, and can later prove possession of such a certificate in an unlinkable way, thereby selectively disclosing chosen attributes to the service provider. Recently, the concept of encrypted ABCs (EABCs) was introduced by Krenn et al. at CANS 2017, where virtually all computation is outsourced to a semi-trusted cloud-provider called wallet, thereby overcoming existing efficiency limitations on the user’s side, and for the first time enabling “privacy-preserving identity management as a service”.
While their approach is highly relevant for bringing ABCs into the real world, we present a simple attack allowing the wallet to learn a user\u27s attributes when colluding with another user -- a scenario which is not covered by their modeling but which needs to be considered in practice. We then revise the model and construction of Krenn et al. in various ways, such that the above attack is no longer possible. Furthermore, we also remove existing non-collusion assumptions between wallet and service provider or issuer from their construction. Our protocols are still highly efficient in the sense that the computational effort on the end user side consists of a single exponentiation only, and otherwise efficiency is comparable to the original work of Krenn et al
Alemtuzumab Induction and Delayed Acute Rejection in Steroid-Free Simultaneous Pancreas-Kidney Transplant Recipients
Transplantation and immunomodulatio
Early Steroid Withdrawal Compared With Standard Immunosuppression in Kidney Transplantation - Interim Analysis of the Amsterdam-Leiden-Groningen Randomized Controlled Trial
Nephrolog
Early Steroid Withdrawal Compared With Standard Immunosuppression in Kidney Transplantation - Interim Analysis of the Amsterdam-Leiden-Groningen Randomized Controlled Trial
Nephrolog
MoniPoly---An Expressive -SDH-Based Anonymous Attribute-Based Credential System
Modern attribute-based anonymous credential (ABC) systems benefit from special encodings that yield expressive and highly efficient show proofs on logical statements. The technique was first proposed by Camenisch and Groß, who constructed an SRSA-based ABC system with prime-encoded attributes that offers efficient AND, OR and NOT proofs. While other ABC frameworks have adopted constructions in the same vein, the Camenisch-Groß ABC has been the most expressive and asymptotically most efficient proof system to date, even if it was constrained by the requirement of a trusted message-space setup and an inherent restriction to finite-set attributes encoded as primes.
In this paper, combining a new set commitment scheme and a SDH-based signature scheme, we present a provably secure ABC system that supports show proofs for complex statements. This construction is not only more expressive than existing approaches, it is also highly efficient under unrestricted attribute space due to its ECC protocols only requiring a constant number of bilinear pairings by the verifier; none by the prover.
Furthermore, we introduce strong security models for impersonation and unlinkability under adaptive active and concurrent attacks to allow for the expressiveness of our ABC as well as for a systematic comparison to existing schemes.
Given this foundation, we are the first to comprehensively formally prove the security of an ABC with expressive show proofs.
Specifically, we prove the security against impersonation under the -(co-)SDH assumption with a tight reduction.
Besides the set commitment scheme, which may be of independent interest, our security models can serve as a foundation for the design of future ABC systems
Early Steroid Withdrawal Compared With Standard Immunosuppression in Kidney Transplantation - Interim Analysis of the Amsterdam-Leiden-Groningen Randomized Controlled Trial
BACKGROUND: The optimal immunosuppressive regimen in kidney transplant recipients, delivering maximum efficacy with minimal toxicity, is unknown. METHODS: The Amsterdam, LEiden, GROningen trial is a randomized, multicenter, investigator-driven, noninferiority, open-label trial in 305 kidney transplant recipients, in which 2 immunosuppression minimization strategies-one consisting of early steroid withdrawal, the other of tacrolimus minimization 6 months after transplantation-were compared with standard immunosuppression with basiliximab, corticosteroids, tacrolimus, and mycophenolic acid. The primary endpoint was kidney function. Secondary endpoints included death, primary nonfunction, graft failure, rejection, discontinuation of study medication, and a combined endpoint of treatment failure. An interim analysis was scheduled at 6 months, that is, just before tacrolimus minimization. RESULTS: This interim analysis revealed no significant differences in Modification of Diet in Renal Disease between the early steroid withdrawal group and the standard immunosuppression groups (43.2 mL/min per 1.73 m2 vs 45.0 mL/min per 1.73 m2, P = 0.408). There were also no significant differences in the secondary endpoints of death (1.0% vs 1.5%; P = 0.737), primary nonfunction (4.1% vs 1.5%, P = 0.159), graft failure (3.1% vs 1.5%, P = 0.370), rejection (18.6% vs 13.6%, P = 0.289), and discontinuation of study medication (19.6% vs 12.6%, P = 0.348). Treatment failure, defined as a composite endpoint of these individual secondary endpoints, was more common in the early steroid withdrawal group (P = 0.027), but this group had fewer serious adverse events and a more favorable cardiovascular risk profile. CONCLUSIONS: Based on these interim results, early steroid withdrawal is a safe short-term immunosuppressive strategy. Long-term outcomes, including a comparison with tacrolimus minimization after 6 months, will be reported in the final 2-year analysis
Where, How, and When: Positioning Posttranslational Modification Within Type 1 Diabetes Pathogenesis
On Linkability and Malleability in Self-blindable Credentials
Contains fulltext :
147332.pdf (preprint version ) (Open Access)13 p
- …
